您的位置: 首页 > 农业专利 > 详情页

COMPOSITION POUR LE TRAITEMENT DU CANCER DESTINEE A INHIBER L'ANGIOGENESE TUMORALE, CONTENANT UN AGENT BLOQUANT EN PROFONDEUR DU VEGF, ET SON PROCEDE DE PREPARATION
专利权人:
INC.;IBENTRUS
发明人:
KIM, HOEON,LEE, HYUN-JU
申请号:
CA3029752
公开号:
CA3029752A1
申请日:
2016.07.05
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present invention relates to a cancer treatment composition for inhibiting angiogenesis, and a preparation method therefor. An angiogenesis inhibitor according to the present invention is a cancer treatment composition containing a fusion protein comprising a vascular endothelial growth factor-binding domain of vascular endothelial growth factor receptor 1 (VEGFR1) and a b1 domain of neuropilin-1 (NRP1). The novel fusion protein is an angiogenesis inhibitor for blocking the binding of VEGF to a receptor thereof in the cell membrane, and has an effect of inhibiting the proliferation of cancer cells and the growth and metastasis of cancer. In addition, the fusion protein can be usable as an anti-cancer agent and exhibits an effective anti-cancer effect at a dose lower than that of a conventional angiogenesis inhibitor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充